194 related articles for article (PubMed ID: 15942711)
21. Immunohistopathological and molecular genetic features of a case in which gastrointestinal stromal tumor recurred five times.
Inoue T; Suzuki T; Nakagawa K; Kurokawa Y; Satomi S; Moriya T; Sasano N; Sasano H
Pathol Int; 2004 Mar; 54(3):196-200. PubMed ID: 14989743
[TBL] [Abstract][Full Text] [Related]
22. A histopathological review of gastrointestinal related mesenchymal tumors: the hidden GIST.
Issakov J; Jiveliouk I; Nachmany I; Klausner J; Merimsky O
Isr Med Assoc J; 2007 Nov; 9(11):810-2. PubMed ID: 18085040
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases.
Herawi M; Montgomery EA; Epstein JI
Am J Surg Pathol; 2006 Nov; 30(11):1389-95. PubMed ID: 17063078
[TBL] [Abstract][Full Text] [Related]
24. [Endoscopic, clinicopathologic and immunohistochemical features of gastric stromal tumor].
Huang KH; Liu JH; Wang LY; Wang LY; Li CQ; Zhu ZH; Li HG
Ai Zheng; 2007 Nov; 26(11):1252-6. PubMed ID: 17991328
[TBL] [Abstract][Full Text] [Related]
25. Complete extragastric growth in a giant gastrointestinal stromal tumor: report of a case.
Funahashi H; Okada Y; Sawai H; Wakasugi T; Akamo Y; Manabe T
Int Surg; 2008; 93(1):45-9. PubMed ID: 18543554
[TBL] [Abstract][Full Text] [Related]
26. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
[TBL] [Abstract][Full Text] [Related]
27. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
[TBL] [Abstract][Full Text] [Related]
28. [Clinical study of gastrointestinal stromal tumors].
Zhang W; Ye ZY; Shao QS; Zhao ZS; Wang YD; Xu XD
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):378-81. PubMed ID: 19598024
[TBL] [Abstract][Full Text] [Related]
29. The cyclin-dependent kinase inhibitor, p27, has no correlation with the malignant potential of GIST.
Shirin H; Kravtsov V; Shahmurov M; Shabat VS; Krinshpon I; Alin A; Avinoach I; Avni Y
Digestion; 2007; 75(1):4-9. PubMed ID: 17406118
[TBL] [Abstract][Full Text] [Related]
30. An audit of surgical management of gastrointestinal stromal tumours (GIST).
Bucher P; Egger JF; Gervaz P; Ris F; Weintraub D; Villiger P; Buhler LH; Morel P
Eur J Surg Oncol; 2006 Apr; 32(3):310-4. PubMed ID: 16414236
[TBL] [Abstract][Full Text] [Related]
31. [Gastrointestinal stromal tumours: clinical and therapeutic features. A report of 25 cases].
Bdioui H; Jouini M; Bouzaiene H; Nouira K; Fteriche F; Ksantini R; Chebbi F; Kacem MJ; Ben Safta Z
Tunis Med; 2006 Oct; 84(10):599-602. PubMed ID: 17193848
[TBL] [Abstract][Full Text] [Related]
32. [Histopathological and cytological findings in a case of gastrointestinal stromal tumor presenting in the pelvic cavity].
Takekawa Y; Kimura M; Sakakibara M; Yoshii R; Yamashita Y
Rinsho Byori; 2007 Jun; 55(6):535-9. PubMed ID: 17657986
[TBL] [Abstract][Full Text] [Related]
33. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.
Blanke CD; Rankin C; Demetri GD; Ryan CW; von Mehren M; Benjamin RS; Raymond AK; Bramwell VH; Baker LH; Maki RG; Tanaka M; Hecht JR; Heinrich MC; Fletcher CD; Crowley JJ; Borden EC
J Clin Oncol; 2008 Feb; 26(4):626-32. PubMed ID: 18235122
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and management of gastrointestinal stromal tumors.
Machado-Aranda D; Malamet M; Chang YJ; Jacobs MJ; Ferguson L; Silapaswan S; Goriel Y; Kolachalam R; Mittal VK
Am Surg; 2009 Jan; 75(1):55-60. PubMed ID: 19213398
[TBL] [Abstract][Full Text] [Related]
35. Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors.
Sun B; Qie S; Zhang S; Sun T; Zhao X; Gao S; Ni C; Wang X; Liu Y; Zhang L
Hum Pathol; 2008 Mar; 39(3):444-51. PubMed ID: 18261629
[TBL] [Abstract][Full Text] [Related]
36. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
Kawai J; Kodera Y; Fujiwara M; Kasai Y; Nagasaka T; Koike M; Hibi K; Ito K; Akiyama S; Nakao A
Hepatogastroenterology; 2005; 52(63):959-64. PubMed ID: 15966241
[TBL] [Abstract][Full Text] [Related]
37. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
Espinosa I; Lee CH; Kim MK; Rouse BT; Subramanian S; Montgomery K; Varma S; Corless CL; Heinrich MC; Smith KS; Wang Z; Rubin B; Nielsen TO; Seitz RS; Ross DT; West RB; Cleary ML; van de Rijn M
Am J Surg Pathol; 2008 Feb; 32(2):210-8. PubMed ID: 18223323
[TBL] [Abstract][Full Text] [Related]
38. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival?
Sandel HD; Day T; Richardson MS; Scarlett M; Gutman KA
Laryngoscope; 2006 May; 116(5):791-5. PubMed ID: 16652089
[TBL] [Abstract][Full Text] [Related]
39. What is the prognostic significance of metastatic lymph nodes in GIST?
Valadão M; de Mello EL; Lourenço L; Vilhena B; Romano S; Castro Ldos S
Hepatogastroenterology; 2008; 55(82-83):471-4. PubMed ID: 18613390
[TBL] [Abstract][Full Text] [Related]
40. High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis.
Lo SS; Wu CW; Chi CW; Li AF; Chen JH; Lui WY
Hepatogastroenterology; 2005; 52(66):1902-4. PubMed ID: 16334803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
